| Literature DB >> 31284412 |
Shicheng Ye1, Jochem W B Boeter1, Louis C Penning1, Bart Spee1, Kerstin Schneeberger2.
Abstract
Bioengineered livers are promising in vitro models for drug testing, toxicological studies, and as disease models, and might in the future be an alternative for donor organs to treat end-stage liver diseases. Liver tissue engineering (LTE) aims to construct liver models that are physiologically relevant. To make bioengineered livers, the two most important ingredients are hepatic cells and supportive materials such as hydrogels. In the past decades, dozens of hydrogels have been developed to act as supportive materials, and some have been used for in vitro models and formed functional liver constructs. However, currently none of the used hydrogels are suitable for in vivo transplantation. Here, the histology of the human liver and its relationship with LTE is introduced. After that, significant characteristics of hydrogels are described focusing on LTE. Then, both natural and synthetic materials utilized in hydrogels for LTE are reviewed individually. Finally, a conclusion is drawn on a comparison of the different hydrogels and their characteristics and ideal hydrogels are proposed to promote LTE.Entities:
Keywords: bioengineered organ; hydrogel; liver; tissue engineering
Year: 2019 PMID: 31284412 PMCID: PMC6784004 DOI: 10.3390/bioengineering6030059
Source DB: PubMed Journal: Bioengineering (Basel) ISSN: 2306-5354
Figure 1Liver histology and extracellular matrix (ECM). (a) A schematic representation of the whole human liver; (b) Schematic overview of the liver lobule; (c) The connection among major liver ECM components seen within the space of Disse.
Characteristics and applications of natural materials.
| Natural Materials | Major Concerned Properties | Applications | References | |||||
|---|---|---|---|---|---|---|---|---|
| Biocompatible | Biodegradable | Hydrophilic | Thermal-Responsible | FDA | Other Characteristics | |||
|
| Yes | Yes, hyaluronidases | Yes | Yes | Approved | Nonimmunogenic, non-adhesive, good swelling and creep compliance properties, photopolymerizable, promote cell mortality and proliferation, reduces long-term inflammation, hepatic elimination | Tissue engineering, wound healing, angiogenesis, etc. | [ |
|
| Yes | Yes, controllable | Yes | Yes | Approved | Nonimmunogenic, bioactive, ease of gelation, suitable for in situ injection; poor elasticity, poor cell adhesion, mechanical weakness, difficulties in handling and sterilization | Tissue engineering and regeneration, as model ECMs, drug delivery | [ |
|
| Yes | Yes | Yes | Yes | Approved | Good permeability, low immunogenicity, poor mechanical properties | Tissue engineering (including cartilage, ligament, vessel etc.) | [ |
|
| Yes | Yes, very fast | Yes | Yes | Approved | Ease of manipulation, high mechanical properties, easy to form films and matrix hydrogels, very viscous polymer, low thermal stability, low cost | Tissue engineering, drug discovery | [ |
|
| Yes | Yes | Yes | Yes | Approved | Noncytotoxic, good thermal and mechanical properties, hydrogels with a high water content | Various derivatives in biomedical field | [ |
|
| Yes | Yes | Yes | Yes | No | Bioactive, mechanical weakness, batch-to-batch variation, undefined composition | 3D models, cell culture, mimic ECMs | [ |
|
| Yes | Yes, lysozyme | Yes | Yes | Approved | Nonimmunogenic, good host response, high antimicrobial activity, very viscous polymer solution and pH-responsive, sufficient mechanical properties | Tissue engineering, e.g., liver, bone, skin, vessels | [ |
|
| Yes | Yes | Yes | Yes | No | High mechanical strength, ability to maintain the cellular phenotype | Mimics the microenvironment for hepatocytes | [ |
|
| Yes | Yes | No | Yes | Approved | Easily autologous isolation, uniform cell distribution, limited mechanical strength, inflammatory response | Tissue engineering scaffolds, blood blotting, fertility preservation | [ |
|
| Yes | Yes | No | Yes | No | Non-toxic, piezoelectric properties, brittleness, tendency to crystallize | Tissue engineering including LTE, drug carrier, would healing | [ |
Abbreviations: Hyaluronic acid, HA; polyhydroxyalkanoates, PHAs; liver tissue engineering, LTE.
Characteristics and applications of synthetic materials.
| Synthetic Materials | Major Concerned Properties | Applications | References | |||||
|---|---|---|---|---|---|---|---|---|
| Biocompatible | Biodegradable | Hydrophilic | Thermal-Responsive | FDA | Other Characteristics | |||
|
| Yes | No | Yes | No | Approved | Various derivatives, excellent optical transparency and stability in water | Degradable or thermal-responsive derivatives for drug delivery | [ |
|
| Yes | No | Yes | Yes | Approved | Inefficient elasticity, stiff membrane, lack of cell adhesion, ease of fabrication and sterilization | Tissue engineering, both medical and nonmedical devices | [ |
|
| Yes | No | Yes | Yes | No | Semiflexible properties, strain stiffening | Tissue engineering and cancer immunotherapy | [ |
|
| Yes | No | Yes | No | Approved | Hydrolytically bioactive, photocrosslinkable, easily modifiable | Widely used in for chemical, biological, and commercial purposes, and also in tissue engineering | [ |
|
| Yes | Yes, controlled | No | Yes | Approved | Poor load-bearing properties, hydrolytically unstable; good cell adhesion and proliferation | Medical devices, drug delivery, fabrication of tissue engineering matrices, suture reinforcements | [ |
|
| Yes | Yes | Yes | No | Approved | Highly crystalline, high melting point, lacks elasticity, not soluble in most organic solvents, tends to lose mechanical strength | Absorbable sutures, orthopedic devices, scaffolding matrices for tissue regeneration | [ |
|
| Yes | Yes, slow | No | No | Approved | Lacks elasticity, high tensile strength, hydrolytically unstable | Orthopedic fixation devices | [ |
|
| Yes, less | Yes. Low rate | No | Yes | Approved | Limited elasticity, tunable mechanical properties | Tissue engineering, long-term drug/vaccine delivery vehicle | [ |
Abbreviations: poly(ethylene glycol), PEG; poly(lactide-co-glycolide) acid, PLGA; polyisocyano peptide, PIC; Poly(vinyl alcohol), PVA; poly(N-vinylpyrrolid), PVP; poly(propylene furmarate-co-ethylene glycol), P(PF-co-EG); poly(2-hydroxyethylmethacrylate), HEMA; poly(acrylic acid), PAA; polyglycolic acid, PGA; polylactic acid, PLA; poly-e-caprolactone, PCL; poly(N-isopropylacrylamide), PNIPAAm.
Hydrogels designed for liver tissue engineering.
| Composition | Cell Source | Crosslinking Method | Output | Reference |
|---|---|---|---|---|
| Collagen, chitosan | Platelet and rat hepatocyte; rat hepatocyte | Chemical crosslinking; noncovalently linked | The matrix has excellent blood and cell compatibility; hepatocytes exhibited relatively high glutamate-oxaloacetate transaminase and glucose secretion functions | [ |
| Collagen, chitosan, heparin | Platelet and rat hepatocyte | Chemical and physical crosslinking | Improved the blood compatability and maintained hepatocyte viability and function; exhibited high urea and triglyceride secretion functions | [ |
| Collagen I, HA | Primary human hepatocytes and liver stellate cells | Physical crosslinking, UV crosslinker | Bioprinted 3D liver tissue constructs maintained liver functions including urea and albumin production | [ |
| Gelatin, chitosan | Human HepG2; primary rat hepatocyte | Crosslinked with 1% genipin; crosslinked by glutaraldehyde solution | Cells cultured in 3D scaffolds preformed better on the structural characteristics, cell viability, growth and liver specific functions; supply living cells with nutrients and allow removing the cell metabolite; hepatocytes perform better in the well-defined scaffold | [ |
| Gelatin, silk fibroin (SF) | Human normal hepatic QZG cell line | Use of glutaraldehyde solution to produce cross-linked gelatin solution and then mix with SF | Achieved better biocompatibility, controlled degradation, and good for the attachment and proliferation of cells | [ |
| Gelatin | Primary rat hepatocytes | Gelatin is dissolved in hot NaCl and Tris-HCl | Rapid prototypedg hepatocytes remained viable and performed biological functions for more than 2 months | [ |
| Gelatin, heparin | Human endothelial cells and HepG2 cells | Physical mixture | Helped cells to reconstruct a patent vascular tree within the decellularized porcine liver scaffold | [ |
| Gelatin, polyurethane | Hepatocyte | Cross-linked with glutaraldehyde, enhanced by the addition of lysine | Generation of a hydrogel with controlled pore size and interconnectivity | [ |
| GelMA | Human HepG2/C3A cells | Photocrosslinked | Bioprinted liver spheroids exhibited long-term functionality | [ |
| HA, PEG | Human HepG2 cells, hiPS-HEPs | Bioorthogonal SPAAC crosslinked, modified with cyclic RGD peptides | hiPS-HEPs migrated and grew in 3D and showed an increased viability and higher albumin production compared to ctrols | [ |
| HA, moieties; collagen III, laminin | Primary rat hepatocytes; hHpSCs | Galactose moieties were covalently coupled with HA through ethylenediamine; the is initiated by a PEGDA cross-linker | Formation of cellular aggregates with enhanced liver specific metabolic activities and improved cell density; permissive for survival and phenotypic stability of human hepatic stem cells and hepatoblasts | [ |
| Fibrin | Rat hepatocyte; human hepatocytes, dermal fibroblasts, and UVECs | Human fibrinogen was applied with the thrombin solution to make the fibrin matrix | Supported engraftment and specific differentiation of viable hepatocytes; stimulated hepatocytes for the ectopic expansion of engineered human liver tissue seeds; in vitro-generated liver tissues can expand and function in vivo | [ |
| Fibrin, PLGA | Rat hepatocytes and ADSCs | Formed by the pollymerization of fibrinogen acted by protease thrombin | Assembled to be an implantable endothelialized liver tissue, along with a hierarchical vascular network | [ |
| Alginate | Mouse primary hepatocytes; HepG2 cells | Freezedry technique; crosslinked in CaCl2 solution | Maintained hepatocyte genotype, produced hepatic-specific proteins for two weeks; liver spheroids displayed an enhanced cell proliferation; importance of cell density within weakly adhesive alginate scaffolds; a cold reduction in temperature display an enhanced cell proliferation | [ |
| Alginate, galactosylated chitosan | Primary hepatocytes | Calcium crosslinked; lyophilization | Enhanced hepatocyte aggregation; improved cell attachment and viability | [ |
| Alginate (Alg), glycyrrhizin (GL), calcium (Ca) | HepG2 cells | Calcium crosslinked equal volume mixture of GL, nano-CaCO3 and Alg | GL–Alg–Ca hydrogel was homogenous complex with stable structure and well viscoelasticity, and cells showed good biocompatibility, and maintained the viability, proliferation and liver function | [ |
| Chitosan | HepG2 cells | The microfluidic fabrication process for pure chitosan microfibers | HepG2 cells were self-aggregated with a spheroid shape, showing a higher liver specific function (albumin secretion and urea synthesis). | [ |
| Lactose-modified chitosan (Lact-CTS) | Normal liver cell | Coupling of lactose with chitosan was carried out by the reducing agent, addition of NaBH4 | Lact-CTS with 48.62% of galactose moieties could facilitate the cell attachment and possess great biocompatibility and mechanical stability | [ |
| Chitosan, gelatin | Hepatoytes | Crosslinked by glutaraldehyde solution | Scaffold produced with predefined multilevel internal architectures (a flow-channel network and hepatic chambers) and improved hepatocytes performance greatly in comparison with a porous scaffold | [ |
| Silk fibroin/chitosan (SFCS) | HepG2 cells | Freezing and lyophilization | Provided a matrix with homogeneous porous structure, controllable pore size and mechanical properties | [ |
| Chitosan nanofibers, fibronectin | Primary rat hepatocytes, endothelial cells | Fabricated by the electrospinning technique | Enhanced cell attachment and maintained their morphologies and functions | [ |
| PHBVHHx | UC-MSCs, hepatocyte cells | Solid–liquid phase separation method to form scaffolds | Injured mice liver were recovered; generated tissue looked similar to the organ | [ |
| Native nanofibrillar cellulose (NFC) | Human hepatic cell lines HepaRG and HepG2 | Physically crosslinked | Provided mechanical support for cell growth and differentiation, and induced spheroid formation of HepaRG and HepG2 cells. | [ |
| Cellulose nanocrystral (CNCs), alginate | Human hepatoma cells, fibroblasts | Crosslinked with CaCl2 | The bioink formulation was suitable to print a liver mimetic honeycomb 3D structure containing fibroblast and heptatoma cells | [ |
| Nanofibrillar cellulose, HA-gelatin | Human HepaRG liver progenitor cells, | HG hydrogel based on thiol-modified HA, thiol-modified gelatin and crosslinker PEGDA | Induced apicobasal polarity and functional bile canaliculi-like structures, expediting the hepatic differentiation of HepaRG liver progenitor cells better than the standard 2D culture | [ |
| Agarose, carbohydrate glass | Primary rat hepatocytes and fibroblasts | Chain entanglements, physical crosslinking | Primary hepatocytes and fibroblasts were cast | [ |
| Agarose–chitosan (AG–CH) | Primary rat hepatocytes | Crosslinke by glutaraldehyde | The hepatic functions like albumin secretion and urea synthesis were established in the 3D scaffold | [ |
| PEG, heparin | Primary rat hepatocytes, BMEL; cryopreserved primary human hepatocytes, induced pluripotent stem cells (iPSCs) | UV light polymerization; chemically crosslinked | Demonstrated the importance of cell–cell and cell–matrix interactions in BMEL cell and primary hepatocyte survival. Aggregation and encapsulation of iPS cells during their differentiation towards hepatocytes yielded microtissues that depicted stable albumin production on-chip and inducible CYP activity. The 3D in vitro liver model is capable of sustaining advanced human-specific liver functions | [ |
| PEG, PLGA, liver-derived ECM (L-ECM), growth factors | Rat liver | Physical and thermal crosslinking | L-ECM and growth factors enhanced tissue penetration into intrahepatically implanted biodegradable scaffolds and induced cell proliferation in the parenchyma that surrounds these scaffolds in the normal liver | [ |
| PEG-DA, PEGDAAm, MMP-sensitive | Primary human fetal liver cells, HUVECs and HepG2 | Chemical crosslinking, photopolymerization | The 3D in vitro liver model is capable of sustaining advanced human-specific liver functions for at least 5 months in culture. Hepatic tissues survived and functioned for over 3 weeks after implantation | [ |
| PIC, GRGDS peptide | Human dermal microvascular endothelial cells and fibroblasts | Polymerization of the corresponding monomers using a nickel perchlorate as a catalyst. | Supported pre-vascularization and the development of organotypic structures | [ |
| PVA | Physical crosslinking by freeze–thaw cycless | Exhibited similar mechanical properties and morphological characteristics to porcine liver | [ | |
| PVA, gelatin | HUVECs and HepG2 | Physically crosslinked by freeze–thaw cycles | Hydrogel particles with a well pronounced tendency towards association with hepatocytes and endothelial cells. | [ |
| PLGA, AVAD; collagen-coated PLGA (C-PLGA); PLGA, gelatin | Pig liver transplantation; rat BMSCs; rat hepatocytes (HCs), nonparenchymal liver cells | Chemical and physical crosslinking | Demonstrated the feasibility of using AVADs in organ transplantation. Proved the superiority of the C-PLGA for hepatocytes differentiation. HCs cocultured with nonparenchymal cells can attach to and survive on the 3D polymer scaffolds. Cells recovered polarity and exhibited improved liver-specific function. Untreated PLGA performed best for supporting liver-specific functions. 3D printing and optimized parameters are applied for liver regeneration. | [ |
| PGA, fibrin | Physical crosslinking | Effective in preventing biliary leakage | [ | |
| PLA | Rat hepatocytes, rat hepatic stellate cells | Dissolved in 2,2,2-trifluoroethanol | Encouraged the rapid self-organization of 3D spheroids and the spheroids formed exhibit hepatocyte-specific functionality | [ |
| PLAL | Rat hepatocyte | Chemical crosslinking | Contributed to hepatocyte engraftment, function, and expansion | [ |
| PLA, fibroin; collagen I; discrete aligned nanofibers | HepG2 cells; rat hepatocyte | Chemical and thermal crosslinking | Improved the cell growth, enhancing cells adhesion and proliferation. Hepatocyte aggregates formed on nanofibers displayed excellent cell retention, cell activity and stable functional expression | [ |
| PLLA, gelatin, HGF | BMSCs | Electrospinning, physical and chemical crosslinking | Effectively guide hepatic commitment of patient derived BMSCs | [ |
| PCL, collagen | Primary rat hepatocytes, HUVECs and human lung fibroblasts (HLFs) | Physical and thermal crosslinking, 3D printing | The vascular formation and functional abilities of HCs demonstrated that the heterotypic interaction among HCs and nonparenchymal cells increased the survivability and functionality of HCs | [ |
| PCL, ECM | HepG2 hepatocytes | Electrospinning, physical and thermal crosslinking | Provided a viable, translatable platform for hepatocytes, supporting in vivo phenotype and function | [ |
| PCL | Human USSCs, self-renewing pluripotent cells | Physical crosslinking, electrospinning | Differentiation of USSCs demonstrated that this culture system can potentially be used as an alternative to the ECM-based culture for relevant hepatocyte-based applications in LTE | [ |
| PCL, chitosan | Epithelial liver mouse cells. | Physical crosslinking, electrospinning | The porosity and pore is suitable for epithelial liver mouse cells infiltration, attachment, and material exchange | [ |
| PAA, PET, collagen | Primary hepatocytes | Chemical an physical crosslinking, UV light induced polymerization | The growth kinetics of adhesion patch at primary hepatocyte cell substrate interface is changed upon PAA grafting | [ |
| PAA, PEI, ELPs | Primary rat hepatocytes, | Chemical an physical crosslinking | ELP–polyelectrolyte conjugates profoundly influenced the morphology, aggregation and differentiation function of primary rat hepatocytes | [ |
Abbreviations: hyaluronic acid, HA; polyhydroxyalkanoates, PHAs; poly(ethylene glycol), PEG; poly(lactide-co-glycolide) acid, PLGA; polyisocyano peptide, PIC; poly(vinyl alcohol), PVA; poly(N-vinylpyrrolid), PVP; poly(propylene furmarate-co-ethylene glycol), P(PF-co-EG); felatin methacryloyl, GelMA;poly(acrylic acid), PAA; poly(ethylene terephthalate), PET; polyethyleneimine, PEI; polyglycolic acid, PGA; polylactic acid, PLA; poly-e-caprolactone, PCL; poly(N-isopropylacrylamide), PNIPAAm; hepatoma cells, HepG2; strain-promoted alkyne-azide 1,3-dipolar cycloaddition, SPAAC; Arg-Gly-Asp, RGD; bone marrow mesenchymal stem cells, BMSCs; matrixmetalloproteinase sensitive peptide, MMP-sensitive; human iPSC derived hepatocytes, hiPS-HEPs; human hepatic stem cells, hHpSCs; (human) umbilical vein endothelial cells, (H)UVECs; adipose-derived stem cells, ADSCs; bipotential mouse embryonic liver cells, BMEL; absorbable vascular anastomotic device, AVAD; elastin-like polypeptides, ELPs; human cord blood-derived unrestricted somatic stem cells, USSCs.
Figure 2Hydrogels for liver tissue engineering (LTE). (a) Hallmarks of tissue engineering; (b) Proposed value of characteristics specific for LTE.